Showing results (21-30 of 523) with videos related to
Sort By:
Pageof 53
The Journal of Clinical Investigation|November 1, 1991
Systemic lysis protects against the effects of platelet activation during coronary thrombolysisD J Fitzgerald, M Hanson, G A FitzGeraldThe Journal of Biological Chemistry|April 25, 1990
The response to thromboxane A2 analogues in human platelets. Discrimination of two binding sites linked to distinct effector systemsK Takahara, R Murray, G A FitzGerald, et al.The Journal of Clinical Investigation|February 1, 1986
Coronary vascular occlusion mediated via thromboxane A2-prostaglandin endoperoxide receptor activation in vivoD J Fitzgerald, J Doran, E Jackson, et al.Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1987
Thromboxane biosynthesis and antagonism in humansG A FitzGerald, D J Fitzgerald, J A Lawson, et al.The New England Journal of Medicine|October 17, 1991
Suppression of thromboxane A2 but not of systemic prostacyclin by controlled-release aspirinR J Clarke, G Mayo, P Price, et al.Journal of Internal Medicine. Supplement|January 1, 1989
Fish oils in cardiovascular diseaseG A Fitzgerald, G Braden, D J Fitzgerald, et al.Circulation|August 1, 1984
The effects of organic nitrates on prostacyclin biosynthesis and platelet function in humansD J Fitzgerald, L Roy, R M Robertson, et al.Circulation|December 1, 1989
Platelet and vascular function during coronary thrombolysis with tissue-type plasminogen activatorD M Kerins, L Roy, G A FitzGerald, et al.Circulation|August 1, 1993
Transdermal modification of platelet function. A dermal aspirin preparation selectively inhibits platelet cyclooxygenase and preserves prostacyclin biosynthesisR M Keimowitz, G Pulvermacher, G Mayo, et al.Circulation|July 1, 1990
Dietary fish oil accelerates the response to coronary thrombolysis with tissue-type plasminogen activator. Evidence for a modest platelet inhibitory effect in vivoG A Braden, H R Knapp, D J Fitzgerald, et al.Pageof 53